July 10, 2017 | Spinal Cord Injury Zone!

Asterias Biotherapeutics Receives FDA Clearance to Enroll C-4 Patients in SCiStar Study

July 10, 2017

Ability to enroll patients with second most common cervical spinal cord injury broadens eligible population for SCiStar study and future trials FREMONT, Calif., July 10,...

The mission of The Spinal Cord Injury Zone is to archive important Spinal Cord Injury News and Spinal Cord Injury Information for education and awareness. The Spinal Cord Injury Zone website is a not-for-profit Spinal Cord Injury educational Knowledge Base.

Daily Archives: July 10, 2017

Asterias Biotherapeutics Receives FDA Clearance to Enroll C-4 Patients in SCiStar Study